Pharmaceutical

Roche records 4% decline in H1 2024 net income

Roche has reported a net income of SFr6.6bn ($7.4bn) in H1 2024, a 4% decline compared to SFr7.5bn ($8.5bn) in H1 2023.

Jul 28, 2024 - 04:00
Roche records 4% decline in H1 2024 net income
Roche has reported a net income of SFr6.6bn ($7.4bn) in H1 2024, a 4% decline compared to SFr7.5bn ($8.5bn) in H1 2023.
Read the original article

Tags:

Previous Article

Cue Biopharma downsizes to focus on autoimmune pipeline

Next Article

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AstraZeneca, maker of FluMist, seeks to allow at-home administration of vaccine

AstraZeneca, maker of FluMist, seeks to allow at-home a...

Oct 24, 2023

Opinion: The end of affirmative action means it’s time to revise pre-med requirements

Opinion: The end of affirmative action means it’s time ...

Nov 11, 2023

STAT+: ‘Doctors need to get on top of this’: GPT-4 displays bias in medical tasks

STAT+: ‘Doctors need to get on top of this’: GPT-4 disp...

Jul 18, 2023